Efficacy of the Bone-anchored Hearing Aid for Unilateral Deafness
NCT ID: NCT00201617
Last Updated: 2015-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2004-07-31
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)
NCT01264510
A Comparison Between Wireless CROS and Bone-anchored Hearing Devices for Single-Sided Deafness: A Pilot Study
NCT01715948
Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss
NCT03327194
Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss
NCT02963974
Evaluation of the Baha SoundArc in Pediatric Patients
NCT03333577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This investigation will show whether the previously reported BAHA benefits at one month post BAHA sound processor fitting, related to speech recognition in noise and subjective satisfaction, persist at one year, and whether learning effects increase the magnitudes of these benefits from one month to one year post BAHA sound processor fitting. This long-term investigation also attempts to resolve the conflicting findings pertaining to the BAHA effect on localization abilities.
Subjects with hearing impairment will comprise 20 adults with single sided deafness who consent to remediation with the BAHA.In order to see how the adults with unilateral hearing loss will differ from the normal-hearing subjects over time, a control group of 20 normal-hearing individuals also will be evaluated over time, to see how closely the results of the unilateral deafness group approximate the results of the normal individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
normal hearing sensitivity
No interventions assigned to this group
2
Unilateral deafness who are implanted with a Bone Anchored Hearing Aid
Bone-anchored hearing aid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone-anchored hearing aid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Deafness is unilateral - complete or near complete
Exclusion Criteria
2. history of drug abuse;
3. psychiatric disease;
4. inability to follow instructions or to participate in follow-up appointments
5. inability to use the BAHA
6. lack of osseo-integration -
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Jacob and Valeria Langeloth Foundation
OTHER
The New York Eye & Ear Infirmary
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher J Linstrom, MD
Role: PRINCIPAL_INVESTIGATOR
New York Eye & Ear Infirmary
Carol A Silverman, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
New York Eye & Ear Infirmary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Eye & Ear Infirmary
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000303
Identifier Type: -
Identifier Source: secondary_id
03.33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.